| CXSS2100030 | 替雷利珠单抗注射液 | tislelizumab | Injection | Biological Products(2.2) | New Drug Application | 2021-03-05 | 百济神州（上海）生物科技有限公司,勃林格殷格翰生物药业（中国）有限公司 | Baiji Shenzhou (Shanghai) Biotechnology Co Ltd;Boehringer Ingelheim Biopharmaceuticals (China) Ltd | Certificate Issued | 2022-01-07 | view |
| CXSL2100061 | 替雷利珠单抗注射液 | tislelizumab | Injection | Biological Products(2.2) | New Drug Application | 2021-02-22 | 百济神州（上海）生物科技有限公司 | Baiji Shenzhou (Shanghai) Biotechnology Co Ltd | In Review | 2021-02-22 | view |
| CXSL2100053 | 替雷利珠单抗注射液 | tislelizumab | Injection | Biological Products(2.2) | New Drug Application | 2021-02-09 | 百济神州（上海）生物科技有限公司 | Baiji Shenzhou (Shanghai) Biotechnology Co Ltd | In Review | 2021-02-09 | view |
| CXSL2100051 | 替雷利珠单抗注射液 | tislelizumab | Injection | Biological Products(2.2) | New Drug Application | 2021-02-09 | 百济神州（上海）生物科技有限公司 | Baiji Shenzhou (Shanghai) Biotechnology Co Ltd | In Review | 2021-02-08 | view |
| CXSS2000014 | 替雷利珠单抗注射液 | tislelizumab | Injection | Biological Products(1) | New Drug Application | 2020-04-23 | 勃林格殷格翰生物药业（中国）有限公司 | Boehringer Ingelheim Biopharmaceuticals (China) Ltd;Baiji Shenzhou (Shanghai) Biotechnology Co Ltd | Certificate Issued | 2021-01-21 | view |
| CYSB2000288 | 替雷利珠单抗注射液 | tislelizumab | Injection | Biological Products(1) | Supplementary Application | 2020-11-14 | 百济神州（上海）生物科技有限公司 | Baiji Shenzhou (Shanghai) Biotechnology Co Ltd;Boehringer Ingelheim Biopharmaceuticals (China) Ltd | Certificate Issued | 2021-01-21 | view |
| CXSB2100007 | 替雷利珠单抗注射液 | tislelizumab | Injection | Biological Products | Supplementary Application | 2021-01-19 | 百济神州（上海）生物科技有限公司 | Baiji Shenzhou (Shanghai) Biotechnology Co Ltd | In Review | 2021-01-19 | view |
| CXSL2100004 | 替雷利珠单抗注射液 | tislelizumab | Injection | Biological Products(2.2) | New Drug Application | 2021-01-06 | 百济神州（上海）生物科技有限公司 | Baiji Shenzhou (Shanghai) Biotechnology Co Ltd | In Review | 2021-01-06 | view |
| CYSB2000223 | 替雷利珠单抗注射液 | tislelizumab | Injection | Biological Products(1) | Supplementary Application | 2020-09-30 | 百济神州（上海）生物科技有限公司 | Baiji Shenzhou (Shanghai) Biotechnology Co Ltd;BeiGene Guangzhou Biologics Manufacturing Co Ltd | In Review | 2020-09-30 | view |
| CXSB2000052 | 替雷利珠单抗注射液 | tislelizumab | Injection | Biological Products(1) | Supplementary Application | 2020-09-12 | 百济神州（上海）生物科技有限公司 | Baiji Shenzhou (Shanghai) Biotechnology Co Ltd | In Review | 2020-09-30 | view |
| CXSB2000024 | 替雷利珠单抗注射液 | tislelizumab | Injection | Biological Products | Supplementary Application | 2020-06-30 | 百济神州（上海）生物科技有限公司 | Baiji Shenzhou (Shanghai) Biotechnology Co Ltd | In Review | 2020-06-29 | view |
| CXSS2000033 | 替雷利珠单抗注射液 | tislelizumab | Injection | Biological Products(1) | New Drug Application | 2020-06-29 | 勃林格殷格翰生物药业（中国）有限公司 | Boehringer Ingelheim Biopharmaceuticals (China) Ltd;Baiji Shenzhou (Shanghai) Biotechnology Co Ltd | In Review | 2020-06-28 | view |
| CXSS2000032 | 替雷利珠单抗注射液 | tislelizumab | Injection | Biological Products(1) | New Drug Application | 2020-06-24 | 勃林格殷格翰生物药业（中国）有限公司 | Boehringer Ingelheim Biopharmaceuticals (China) Ltd;Baiji Shenzhou (Shanghai) Biotechnology Co Ltd | In Review | 2020-06-23 | view |
| CXSB2000018 | 替雷利珠单抗注射液 | tislelizumab | Injection | Biological Products | Supplementary Application | 2020-06-13 | 百济神州（上海）生物科技有限公司 | Baiji Shenzhou (Shanghai) Biotechnology Co Ltd | In Review | 2020-06-12 | view |
| CXSB2000014 | 替雷利珠单抗注射液 | tislelizumab | Injection | Biological Products | Supplementary Application | 2020-05-19 | 百济神州（上海）生物科技有限公司 | Baiji Shenzhou (Shanghai) Biotechnology Co Ltd | In Review | 2020-05-18 | view |
| CXSB2000015 | 替雷利珠单抗注射液 | tislelizumab | Injection | Biological Products | Supplementary Application | 2020-05-19 | 百济神州（上海）生物科技有限公司 | Baiji Shenzhou (Shanghai) Biotechnology Co Ltd | In Review | 2020-05-18 | view |
| CXSB2000008 | 替雷利珠单抗注射液 | tislelizumab | Injection | Biological Products | Supplementary Application | 2020-04-22 | 百济神州（上海）生物科技有限公司 | Baiji Shenzhou (Shanghai) Biotechnology Co Ltd | In Review | 2020-04-21 | view |
| CXSS1900025 | 替雷利珠单抗注射液 | tislelizumab | Injection | Biological Products(1) | New Drug Application | 2019-06-03 | 勃林格殷格翰生物药业（中国）有限公司 | Boehringer Ingelheim Biopharmaceuticals (China) Ltd;Baiji Shenzhou (Shanghai) Biotechnology Co Ltd | Certificate Issued | 2020-04-14 | view |
| CXSS1800019 | 替雷利珠单抗注射液 | tislelizumab | Injection | Biological Products(1) | New Drug Application | 2018-09-06 | 勃林格殷格翰生物药业（中国）有限公司 | Boehringer Ingelheim Biopharmaceuticals (China) Ltd;Baiji Shenzhou (Shanghai) Biotechnology Co Ltd | Certificate Issued | 2020-01-06 | view |
| CXSL1900146 | 替雷利珠单抗注射液 | tislelizumab | Injection | Biological Products(1) | New Drug Application | 2019-12-21 | 百济神州（上海）生物科技有限公司 | Baiji Shenzhou (Shanghai) Biotechnology Co Ltd | In Review | 2019-12-19 | view |
